| ISSN |
1948-5190 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Remimazolam for sedation in gastrointestinal endoscopy: A comprehensive review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dushyant Singh Dahiya, Ganesh Kumar, Syeda Parsa, Manesh Kumar Gangwani, Hassam Ali, Amir Humza Sohail, Saqr Alsakarneh, Umar Hayat, Sheza Malik, Yash R Shah, Bhanu Siva Mohan Pinnam, Sahib Singh, Islam Mohamed, Adishwar Rao, Saurabh Chandan and Mohammad Al-Haddad |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dushyant Singh Dahiya, MD, Doctor, Division of Gastroenterology, Hepatology & Motility, The University of Kansas School of Medicine, 2000 Olathe Blvd, Kansas City, KS 66160, United States. dush.dahiya@gmail.com |
| Key Words |
Remimazolam; Endoscopy; Sedation; Outcomes; Efficacy; Safety; Pharmacokinetics |
| Core Tip |
Procedural sedation is a key component of diagnostic and therapeutic gastrointestinal (GI) procedures. It maximizes patient comfort and improves procedural outcomes. Propofol is currently a gold standard for procedural sedation in most parts of the world. However, in recent years, Remimazolam, an ultra-short acting benzodiazepine sedative, is gaining popularity among anesthesiologists and endoscopists for its favorable pharmacology, efficacy, and safety profile. In contrast to other sedatives, particularly Propofol, Remimazolam has lower incidence of intra-procedural hemodynamic instability and respiratory depression. This comprehensive review highlights how Remimazolam can shape the future of GI endoscopy. |
| Publish Date |
2024-07-08 08:09 |
| Citation |
<p>Dahiya DS, Kumar G, Parsa S, Gangwani MK, Ali H, Sohail AH, Alsakarneh S, Hayat U, Malik S, Shah YR, Pinnam BSM, Singh S, Mohamed I, Rao A, Chandan S, Al-Haddad M. Remimazolam for sedation in gastrointestinal endoscopy: A comprehensive review. <i>World J Gastrointest Endosc</i> 2024; 16(7): 385-395</p> |
| URL |
https://www.wjgnet.com/1948-5190/full/v16/i7/385.htm |
| DOI |
https://dx.doi.org/10.4253/wjge.v16.i7.385 |
